The concomitant usage of oxycodone HCl with all cytochrome P450 3A4 inhibitors may perhaps bring about a rise in oxycodone plasma concentrations, which could increase or prolong adverse reactions and will trigger likely deadly respiratory despair. On top of that, discontinuation of a concomitantly made use of cytochrome P450 3A4 inducer could cause